Researcher
Rachel Andres
Principal Investigator
Dr. Robert Laprairie
Institution
University of Saskatchewan
Grant Type
Undergraduate
Disorder
About the researcher
Rachel Andres
Undergraduate Student at the University of Saskatchewan
While there has been great research to clarify the risks and therapeutic potential of Cannabis, these studies have almost exclusively focused on two Cannabinoids: THC and CBD. This study set out to understand the differences between intoxication levels induced by THCP and THC in order to inform policies for possible therapeutic use.
This project investigated the toxicity levels of THCP, a new cannabinoid thought to be more potent than THC. These researchers wished to uncover what this higher potency means for Cannabis recommendations and will be a critical first step in developing policies for Cannabis use. Their findings revealed no discernible difference in behavior between the two, potentially rewriting the rules of THCP’s usage in therapy.
Once further research is done, standards for THCP usage in therapeutic contexts will be clarified.
Our Address
Branch Out Neurological Foundation
care of Thin Air Labs Inc.
P.O. Box 13141 Calgary, AB
T2R 1C6
